Wilson HTM analyst Graham Wald has put out a sell on Avexa.http://news.theage.com.au/business/progen-to-buy-avexa-at-discount-20081222-73k9.html
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025